CIK 0000886163 · Large accelerated filer
LIGAND PHARMACEUTICALS INC
Sign in to watch- Tickers
- LGND LGNDZ LGNXZ LGNYZ LGNZZ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770160744
- Phone
- 858-550-7500
- Business address
- 3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
- Former names
- LIGAND PHARMACEUTICALS
Securities
- LGND Common Stock Nasdaq
- LGNDZ Common stock OTC
- LGNXZ Common stock OTC
- LGNYZ Common stock OTC
- LGNZZ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $6,585,411
- in 7 filings, $4.5M under 10b5-1 plans
Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-26 | FOEHR MATTHEW W President and COO | Grant or award | +7,396 | 179,525 | ||
| 2022-01-26 | FOEHR MATTHEW W President and COO | Shares withheld for taxes | −1,937 | $113.68 | $220K | 177,588 |
| 2022-01-26 | FOEHR MATTHEW W President and COO | Shares withheld for taxes | −3,188 | $113.68 | $362K | 174,400 |
| 2021-11-16 | LAMATTINA JOHN L Director | Option exercise | +4,835 | $32.30 | $156K | 30,233 |
| 2021-11-16 | LAMATTINA JOHN L Director | Sale | −4,835 | $161.86 | $783K | 25,398 |
| 2021-11-16 | LAMATTINA JOHN L Director | Option exercise · Non-Qualified Stock Option (right to buy) | −4,835 | 0 | ||
| 2021-11-12 | HIGGINS JOHN L Chief Executive Officer | Sale | −3,000 | $160.50 | $482K | 335,095 |
| 2021-11-11 | FOEHR MATTHEW W President and COO | Option exercise | +1,028 | $100.38 | $103K | 166,525 |
| 2021-11-11 | FOEHR MATTHEW W President and COO | Option exercise | +11,160 | $21.92 | $245K | 177,685 |
| 2021-11-11 | FOEHR MATTHEW W President and COO | Sale | −11,160 | $163.02 | $1.8M | 166,525 |
| 2021-11-11 | FOEHR MATTHEW W President and COO | Option exercise · Employee Stock Option (right to buy) | −11,160 | 0 | ||
| 2021-11-11 | FOEHR MATTHEW W President and COO | Option exercise · Employee Stock Option (right to buy) | −1,028 | 24,348 | ||
| 2021-08-04 | FOEHR MATTHEW W President and COO | Option exercise | +8,840 | $21.92 | $194K | 173,195 |
| 2021-08-04 | FOEHR MATTHEW W President and COO | Sale | −8,840 | $109.67 | $970K | 164,355 |
| 2021-08-04 | FOEHR MATTHEW W President and COO | Option exercise | +1,142 | $85.79 | $98K | 165,497 |
| 2021-08-04 | FOEHR MATTHEW W President and COO | Option exercise · Employee Stock Option (right to buy) | −8,840 | 11,160 | ||
| 2021-08-04 | FOEHR MATTHEW W President and COO | Option exercise · Employee Stock Option (right to buy) | −1,142 | 25,938 | ||
| 2021-07-12 | Cochran Jennifer R. Director | Grant or award | +1,161 | 1,161 | ||
| 2021-07-12 | Cochran Jennifer R. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +4,508 | 4,508 | ||
| 2021-06-30 | HIGGINS JOHN L Chief Executive Officer | Other acquisition | +247 | $85.91 | $21K | 338,095 |
Page 32 of 43 · 858 trades